• Skip to primary navigation
  • Skip to main content
SRI InternationalSRI mobile logo

SRI International

SRI International - American Nonprofit Research Institute

  • About
    • Blog
    • Press room
  • Expertise
    • Advanced imaging systems
    • Artificial intelligence
    • Biomedical R&D services
    • Biomedical sciences
    • Computer vision
    • Cyber & formal methods
    • Education and learning
    • Innovation strategy and policy
    • National security
    • Ocean & space
    • Quantum
    • QED-C
    • Robotics, sensors & devices
    • Speech & natural language
    • Video test & measurement
  • Ventures
  • NSIC
  • Careers
  • Contact
  • 日本支社
Show Search
Hide Search
October 21, 2021

Biomedical research & development services

SRI Biosciences provides services that span all stages of drug and diagnostics discovery and nonclinical development leading to human clinical trials and, ultimately, to the market.

Contact Us

ian-colrain

“SRI conducts a broad range of services to support the development of biomedical products, advancing them from Idea to IND®, through to clinical trials and to ultimate market approval. ”

Ian M. Colrain

President, Biosciences Division

Featured research & development services

SRI Biosciences partners with clients to seamlessly integrate basic research, drug discovery, and nonclinical and clinical development. Our turnkey and customized services include models for research and drug discovery; identifying targets and mechanisms of action; efficacy; pharmacology and pharmacokinetics; safety; and clinical research studies.

Nonclinical development

SRI offers comprehensive services in drug metabolism and pharmacokinetics, safety toxicology, safety pharmacology, and developmental and reproductive toxicology. Our expertise spans a wide range of pharmaceutical and therapeutic agents and we also offer testing of genetically engineered products and medical devices, such as combination 5d10(k) products, using protocols designed to meet your needs.

Download the brochure

Formulation and manufacturing

SRI’s preformulation and formulation services help optimize safety and efficacy in drug development. Offerings range from preparation of dose formulations for nonclinical in vitro and in vivo safety studies, to cGMP manufacture and stability testing of finished drug product dosage forms for clinical trials.

Download the brochure

Clinical research

Clients can benefit from SRI’s medical expertise for clinical trial execution. With our team of strategic partners, we offer a full scope of services for clinical trials – from protocol development to final clinical study report.

In addition, SRI’s Human Sleep Lab has experience and expertise to validate, develop and test investigational devices within the sleep technology space.

Download the brochure

Research & development services

See our full list of services below and fill out the contact form to learn more about how we can meet your specific needs.

Discovery services

  • ADMET & in vitro metabolism
  • Cell-based assays
  • Drug metabolism and PK
  • Electrophysiology
  • Imaging analysis
  • Immunology assays
  • Magnetic resonance imaging (MRI)
  • Medicinal chemistry and custom synthesis
  • Neurological/ neurodegenerative disorders
  • Functional genomics and proteomics
  • Radiation biology and models
  • Sleep, circadian rhythm
  • Toxin models
  • Viral models

Chemical Manufacturing and Controls (CMC)

  • Analytical chemistry
  • Clinical manufacturing
  • Formulation development

Nonclinical development

  • Bioanalytical chemistry
  • Clinical laboratory services
  • Development and reproductive toxicology
  • Genetic toxicity
  • Immunology services
  • Molecular biology
  • Pharmacokinetic/drug metabolism
  • Toxicology and safety

Clinical research

  • Early phase clinical trials
  • Multiple site trial
  • Clinical research in human sleep and physiology

Case studies

Case Study

Formulating a solution to mass radiation exposure

Case Study

HOPO: Partnering to Advance Therapy for Radiation Exposure

Case Study

Partnering to Rapidly Advance ZMapp TM for Ebola Treatment

Some of our innovators

leyi-gong-bio-pic

Leyi Gong

Program Director, Medicinal Chemistry, Medicinal and Synthetic Chemistry

carol-green-bio-pic

Carol Green

Senior Director, Preclinical Development

michael-greenstein-bio-pic

Michael Greenstein

Sensing and Diagnostics Lab Director, SRI Biosciences

gita-shankar-bio-pic

Gita Shankar

Director, Formulations R&D, Pharmaceutical Sciences

naseem-chini-bio-pic

Naseem Chini

Director, Clinical Analysis Laboratory

Default bio image

Michael McGuire

Research Scientist, Brown Laboratory, Macromolecular Sciences

How can we help?

Once you hit send…

We’ll match your inquiry to the person who can best help you.

Expect a response within 48 hours.

Our privacy policy
Career call to action image

Make your own mark.

Search jobs
Our work

Case studies

Publications

Timeline of innovation

Areas of expertise

Blog

Institute

Leadership

Press room

Media inquiries

Compliance

Privacy policy

Careers

Job listings

Contact

SRI Ventures

Our locations

Headquarters

333 Ravenswood Ave
Menlo Park, CA 94025 USA

+1 (650) 859-2000

Subscribe to our newsletter

日本支社

SRI International

  • Privacy Policy
  • Cookies
  • DMCA
  • Copyright © 2022 SRI International